Coherus BioSciences (CHRS) Reports Q1 Loss Per Share of $1.22
Tweet
Share
E-mailGet Alerts CHRS Hot Sheet
Price: $1.17 -3.31%
Financial Fact:
Occupancy and buying expenses: 81.34M
Today's EPS Names:
ITG, MTEX, NSYS, More
Financial Fact:
Occupancy and buying expenses: 81.34M
Today's EPS Names:
ITG, MTEX, NSYS, More
Join SI Premium – FREE
Coherus BioSciences (NASDAQ: CHRS) reported Q1 EPS of ($1.22), versus ($6.03) reported last year.
For earnings history and earnings-related data on Coherus BioSciences (CHRS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- ITG (ITG) Tops Q2 EPS by 1c
- Epsilon Energy Ltd. (EPSN) Reports Q2 EPS of $0.23
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
